BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 19451745)

  • 1. Effect of c-MYC and E2F1 gene silencing and of 5-azacytidine treatment on telomerase activity in pancreatic cancer-derived cell lines.
    Kumari A; Srinivasan R; Wig JD
    Pancreatology; 2009; 9(4):360-8. PubMed ID: 19451745
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of HPV oncoproteins and cellular factors in maintenance of hTERT expression in cervical carcinoma cells.
    Jeong Seo E; Jung Kim H; Jae Lee C; Tae Kang H; Seong Hwang E
    Gynecol Oncol; 2004 Jul; 94(1):40-7. PubMed ID: 15262117
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of human telomerase activity: repression by normal chromosome 3 abolishes nuclear telomerase reverse transcriptase transcripts but does not affect c-Myc activity.
    Ducrest AL; Amacker M; Mathieu YD; Cuthbert AP; Trott DA; Newbold RF; Nabholz M; Lingner J
    Cancer Res; 2001 Oct; 61(20):7594-602. PubMed ID: 11606399
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Demethylating reagent 5-azacytidine inhibits telomerase activity in human prostate cancer cells through transcriptional repression of hTERT.
    Kitagawa Y; Kyo S; Takakura M; Kanaya T; Koshida K; Namiki M; Inoue M
    Clin Cancer Res; 2000 Jul; 6(7):2868-75. PubMed ID: 10914736
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genistein represses telomerase activity via both transcriptional and posttranslational mechanisms in human prostate cancer cells.
    Jagadeesh S; Kyo S; Banerjee PP
    Cancer Res; 2006 Feb; 66(4):2107-15. PubMed ID: 16489011
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lysine-specific demethylase 1 (LSD1) Is required for the transcriptional repression of the telomerase reverse transcriptase (hTERT) gene.
    Zhu Q; Liu C; Ge Z; Fang X; Zhang X; Strååt K; Björkholm M; Xu D
    PLoS One; 2008 Jan; 3(1):e1446. PubMed ID: 18197256
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RNAi-hTERT inhibition hepatocellular carcinoma cell proliferation via decreasing telomerase activity.
    Zhang PH; Zou L; Tu ZG
    J Surg Res; 2006 Mar; 131(1):143-9. PubMed ID: 16298398
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevated telomerase activity, c-MYC-, and hTERT mRNA expression: association with tumour progression in malignant lipomatous tumours.
    Schneider-Stock R; Boltze C; Jäger V; Epplen J; Landt O; Peters B; Rys J; Roessner A
    J Pathol; 2003 Apr; 199(4):517-25. PubMed ID: 12635143
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Telomerase and c-myc expression in hepatocellular carcinomas.
    Liu YC; Chen CJ; Wu HS; Chan DC; Yu JC; Yang AH; Cheng YL; Lee SC; Harn HJ
    Eur J Surg Oncol; 2004 May; 30(4):384-90. PubMed ID: 15063891
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Telomerase activity in human hepatocellular carcinoma: parallel correlation with human telomerase reverse transcriptase (hTERT) mRNA isoform expression but not with cell cycle modulators or c-Myc expression.
    Chen CJ; Tsai NM; Liu YC; Ho LI; Hsieh HF; Yen CY; Harn HJ
    Eur J Surg Oncol; 2002 Apr; 28(3):225-34. PubMed ID: 11944954
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Upstream stimulatory factor (USF) as a transcriptional suppressor of human telomerase reverse transcriptase (hTERT) in oral cancer cells.
    Chang JT; Yang HT; Wang TC; Cheng AJ
    Mol Carcinog; 2005 Nov; 44(3):183-92. PubMed ID: 16010690
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of transcription factor E2F1 and telomerase in glioblastomas: mechanistic linkage and prognostic significance.
    Alonso MM; Fueyo J; Shay JW; Aldape KD; Jiang H; Lee OH; Johnson DG; Xu J; Kondo Y; Kanzawa T; Kyo S; Bekele BN; Zhou X; Nigro J; McDonald JM; Yung WK; Gomez-Manzano C
    J Natl Cancer Inst; 2005 Nov; 97(21):1589-600. PubMed ID: 16264179
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methylation of the human telomerase gene CpG island.
    Dessain SK; Yu H; Reddel RR; Beijersbergen RL; Weinberg RA
    Cancer Res; 2000 Feb; 60(3):537-41. PubMed ID: 10676632
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The telomerase reverse transcriptase (hTERT) gene is a direct target of the histone methyltransferase SMYD3.
    Liu C; Fang X; Ge Z; Jalink M; Kyo S; Björkholm M; Gruber A; Sjöberg J; Xu D
    Cancer Res; 2007 Mar; 67(6):2626-31. PubMed ID: 17363582
    [TBL] [Abstract][Full Text] [Related]  

  • 15. hTERT expression in sporadic renal cell carcinomas.
    Paradis V; Bièche I; Dargère D; Bonvoust F; Ferlicot S; Olivi M; Lagha NB; Blanchet P; Benoît G; Vidaud M; Bedossa P
    J Pathol; 2001 Sep; 195(2):209-17. PubMed ID: 11592100
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Demethylation of the human telomerase catalytic subunit (hTERT) gene promoter reduced hTERT expression and telomerase activity and shortened telomeres.
    Guilleret I; Benhattar J
    Exp Cell Res; 2003 Oct; 289(2):326-34. PubMed ID: 14499633
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of plasmid-mediated RNA interference targeting telomerase reverse transcriptase on lung cancer cells.
    Ge L; Deng Z; Zhang Y; Shao W; Qiu Y; Cui D; Huang D
    Oncol Rep; 2011 Dec; 26(6):1487-95. PubMed ID: 21922145
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Relationship among telomerase activity, expression of human telomerase reverse transcriptase (hTERT), and expression of c-myc in acute leukemia].
    Cheng X; Chen ZX; Wang W; Fu JX; Cen JN; Yao L
    Ai Zheng; 2003 Nov; 22(11):1175-9. PubMed ID: 14613647
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genistein induces cell growth inhibition in prostate cancer through the suppression of telomerase activity.
    Ouchi H; Ishiguro H; Ikeda N; Hori M; Kubota Y; Uemura H
    Int J Urol; 2005 Jan; 12(1):73-80. PubMed ID: 15661057
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Down-regulation of c-myc and Cyclin D1 genes by antisense oligodeoxy nucleotides inhibits the expression of E2F1 and in vitro growth of HepG2 and Morris 5123 liver cancer cells.
    Simile MM; De Miglio MR; Muroni MR; Frau M; Asara G; Serra S; Muntoni MD; Seddaiu MA; Daino L; Feo F; Pascale RM
    Carcinogenesis; 2004 Mar; 25(3):333-41. PubMed ID: 14604889
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.